M3 Advisory Group’s Eli Lilly LLY Stock Holding History

M3 Advisory Group's LLY Position: Q2 2026 in Review

M3 Advisory Group increased its Eli Lilly (LLY) stake by 4.1% in Q2 2026, buying an estimated $34.7K and bringing the position to 867 shares worth $1.04M. The position accounts for 0.54% of the portfolio, ranked #40.

M3 Advisory Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

• M3 Advisory Group held 867 shares of Eli Lilly worth $1.04M as of Q2 2026.
• M3 Advisory Group bought 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
• Eli Lilly made up 0.54% of M3 Advisory Group's portfolio in Q2 2026, its #40 holding.
• M3 Advisory Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
• 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on M3 Advisory Group's 13F filing for Q2 2026, filed 24 Jul 2026.